Biophore India Pharmaceutical

Healthcare

Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment

Instaa PR - January 24, 2022

· Can market in India and 104 other countries · Has also received DCGI regulatory license for Indian market · Licenses applicable for both API and finished product Biophore India...

Latest news

Apollo Techno Industries Limited files DRHP for IPO: Advocates sustainability in listing on a stock exchange

April 4, 2025

Super Iron Foundry Ltd plans to raise up to Rs. 68.05 crore from Public Issue; IPO opens on March 11

April 3, 2025

Glib AI: The Best Bank Statement Analyzer for Smarter, Faster, and Risk-Free Lending

April 3, 2025

IndusInd Bank: A Strong and Promising Future Ahead

April 3, 2025

Shree Ahimsa Naturals Limited IPO Opens on 25th March, 2025

April 3, 2025

- Advertisement -

Biophore India Pharmaceutical

Latest news

Apollo Techno Industries Limited files DRHP for IPO: Advocates sustainability in listing on a stock exchange

Super Iron Foundry Ltd plans to raise up to Rs. 68.05 crore from Public Issue; IPO opens on March 11

Glib AI: The Best Bank Statement Analyzer for Smarter, Faster, and Risk-Free Lending

IndusInd Bank: A Strong and Promising Future Ahead

Shree Ahimsa Naturals Limited IPO Opens on 25th March, 2025

About Us

Popular Category

Editor Picks

Apollo Techno Industries Limited files DRHP for IPO: Advocates sustainability in listing on a stock exchange

Super Iron Foundry Ltd plans to raise up to Rs. 68.05 crore from Public Issue; IPO opens on March 11